PALISSON ETCHARREN, FRANCIS
Preferred name
PALISSON ETCHARREN, FRANCIS
Official Name
PALISSON ETCHARREN, FRANCIS
Main Affiliation
Email
fpalisson@udd.cl
ORCID
0000-0001-9196-841X
Scopus Author ID
18037973900
41 results
Now showing 1 - 10 of 41
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, KLHL24 mutation drives intermediate filament degradation, mitochondrial dysfunction and fibrosis in heart failure patients(2025) ;RODRIGO ANDRES IBAÑEZ ARENAS ;ANDRES SCHUSTER PINTO; ; 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, <i>De Novo COL7A1</i> mutation in a patient with trisomy 21: coexistence of dystrophic epidermolysis bullosa and Down syndrome(2012) ;Javiera A. Catalán ;Fernando A. Rodríguez ;María J. Yubero; María J. Gana<jats:title>Abstract</jats:title><jats:p><jats:bold>Background </jats:bold> Down syndrome (DS) is the most common autosomal chromosomal disorder. Epidermolysis bullosa (EB) is a rare genodermatosis characterized by skin and mucous membrane fragility, with formation of blisters and erosions after minor trauma. Dystrophic EB (DEB) is inherited as an autosomal dominant (DDEB) or recessive (RDEB) trait. Both forms are caused by mutations in <jats:italic>COL7A1</jats:italic>, the gene coding for the type VII collagen. We report a patient affected by both conditions: DS and DDEB.</jats:p><jats:p><jats:bold>Methods </jats:bold> A patient with DS developed generalized blisters at the age of three months. Cytogenetic study was performed to confirm DS. Skin biopsies were examined with immunohistochemical and electron microscopy techniques to determine EB subtype. Genomic DNA was extracted from peripheral blood samples. <jats:italic>COL7A1</jats:italic> mutations were screened by heteroduplex analysis using conformation‐sensitive gel electrophoresis and sequencing.</jats:p><jats:p><jats:bold>Results </jats:bold> Karyotype analysis revealed trisomy 21. Histological study agreed with a DEB diagnosis. Mutational analysis showed a heterozygous c.6127G>T mutation in <jats:italic>COL7A1</jats:italic>, which is compatible with DDEB. Parental study suggests that c.6127G>T arises as a <jats:italic>de novo</jats:italic> mutation.</jats:p><jats:p><jats:bold>Conclusions </jats:bold> This report demonstrates that EB can be associated with other common conditions and reports the case of a patient who suffered two <jats:italic>de novo</jats:italic> independent genetic conditions. It also contributes to expanding the knowledge and database of clinical and molecular aspects of DDEB.</jats:p>32Scopus© Citations 3 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Ancestral patterns of recessive dystrophic epidermolysis bullosa mutations in Hispanic populations suggest sephardic ancestry(2021) ;Emily Mira Warshauer ;Adam Brown; ;Jonathan ShorttChris Gignoux19Scopus© Citations 7 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Manifestaciones orales de la epidermolisis bulosa en el niño(Sociedad Chilena de Pediatria, 2005-12) ;Alex Vargas D ;Leonor Palomer R2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study(2024) ;J. Bremer ;H. H. Pas ;G. F. H. Diercks ;H. J. MeijerS. M. van der Molen<jats:title>Abstract</jats:title><jats:p>Epidermolysis bullosa (EB) is a heritable skin blistering disease caused by variants in genes coding for proteins that secure cell–cell adhesion and attachment of the epidermis to the dermis. Interestingly, several proteins involved in inherited EB are also associated with autoimmune blistering diseases (AIBD). In this study, we present a long‐term follow‐up of 15 patients suffering from recessive dystrophic or junctional EB. From these patients, 62 sera were analysed for the presence of autoantibodies associated with AIBD. We show that patients suffering from recessive dystrophic EB (RDEB) are more susceptible to developing autoantibodies against skin proteins than patients suffering from junctional EB (70% vs. 20%, respectively). Interestingly, no correlation with age was observed. Most patients showed reactivity to Type XVII collagen/linear IgA bullous dermatosis autoantigen (<jats:italic>n</jats:italic> = 5; 33%), followed by BP230 (<jats:italic>n</jats:italic> = 4; 27%), Type VII collagen (<jats:italic>n</jats:italic> = 4; 27%) and laminin‐332 (<jats:italic>n</jats:italic> = 1; 7%). The pathogenicity of these autoantibodies remains a subject for future experiments.</jats:p>Scopus© Citations 3 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa(2024) ;Grace Tartaglia; ;Neil Patel ;Abigail VarugheseLauren E Israel<jats:title>Abstract</jats:title><jats:p>Recessive dystrophic epidermolysis bullosa (RDEB) is a rare inherited skin disease characterized by defects in type VII collagen leading to a range of fibrotic pathologies resulting from skin fragility, aberrant wound healing, and altered dermal fibroblast physiology. Using a novel in vitro model of fibrosis based on endogenously produced extracellular matrix, we screened an FDA-approved compound library and identified antivirals as a class of drug not previously associated with anti-fibrotic action. Preclinical validation of our lead hit, daclatasvir, in a mouse model of RDEB demonstrated significant improvement in fibrosis as well as overall quality of life with increased survival, weight gain and activity, and a decrease in pruritus-induced hair loss. Immunohistochemical assessment of daclatasvir-treated RDEB mouse skin showed a reduction in fibrotic markers, which was supported by in vitro data demonstrating TGFβ pathway targeting and a reduction of total collagen retained in the extracellular matrix. Our data support the clinical development of antivirals for the treatment of patients with RDEB and potentially other fibrotic diseases.</jats:p>Scopus© Citations 1 4 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Collagen VII maintains proteostasis in dermal fibroblasts by scaffolding TANGO1 cargo(2022) ;Qingqing Cao ;Grace Tartaglia ;Michael Alexander ;Pyung Hung ParkShiv PoojanScopus© Citations 9 7 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Scopus© Citations 11 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Novel and recurrent COL7A1 mutations in Chilean patients with dystrophic epidermolysis bullosa(2012) ;Fernando A. Rodríguez ;María José Gana; ;Gisela ZillmannSusanne M. KrämerScopus© Citations 14 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 1